# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-094542
Filing Date
2026-08-12
Accepted
2026-08-12 08:35:13
Documents
41
Period of Report
2026-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | apre-20260812x8k.htm iXBRL | 8-K | 41188
2 | EX-99.1 | apre-20260812xex99d1.htm | EX-99.1 | 156741
3 | EX-99.2 | apre-20260812xex99d2.htm | EX-99.2 | 49289
4 | GRAPHIC | apre-20260812xex99d1001.jpg | GRAPHIC | 5545
5 | GRAPHIC | apre-20260812xex99d2g001.jpg | GRAPHIC | 156315
6 | GRAPHIC | apre-20260812xex99d2g002.jpg | GRAPHIC | 321149
7 | GRAPHIC | apre-20260812xex99d2g003.jpg | GRAPHIC | 191539
8 | GRAPHIC | apre-20260812xex99d2g004.jpg | GRAPHIC | 162432
9 | GRAPHIC | apre-20260812xex99d2g005.jpg | GRAPHIC | 168697
10 | GRAPHIC | apre-20260812xex99d2g006.jpg | GRAPHIC | 86151
11 | GRAPHIC | apre-20260812xex99d2g007.jpg | GRAPHIC | 225595
12 | GRAPHIC | apre-20260812xex99d2g008.jpg | GRAPHIC | 174240
13 | GRAPHIC | apre-20260812xex99d2g009.jpg | GRAPHIC | 138891
14 | GRAPHIC | apre-20260812xex99d2g010.jpg | GRAPHIC | 148821
15 | GRAPHIC | apre-20260812xex99d2g011.jpg | GRAPHIC | 140312
16 | GRAPHIC | apre-20260812xex99d2g012.jpg | GRAPHIC | 148402
17 | GRAPHIC | apre-20260812xex99d2g013.jpg | GRAPHIC | 112781
18 | GRAPHIC | apre-20260812xex99d2g014.jpg | GRAPHIC | 179771
19 | GRAPHIC | apre-20260812xex99d2g015.jpg | GRAPHIC | 80464
20 | GRAPHIC | apre-20260812xex99d2g016.jpg | GRAPHIC | 97951
21 | GRAPHIC | apre-20260812xex99d2g017.jpg | GRAPHIC | 173282
22 | GRAPHIC | apre-20260812xex99d2g018.jpg | GRAPHIC | 151156
23 | GRAPHIC | apre-20260812xex99d2g019.jpg | GRAPHIC | 213876
24 | GRAPHIC | apre-20260812xex99d2g020.jpg | GRAPHIC | 169432
25 | GRAPHIC | apre-20260812xex99d2g021.jpg | GRAPHIC | 159274
26 | GRAPHIC | apre-20260812xex99d2g022.jpg | GRAPHIC | 95739
27 | GRAPHIC | apre-20260812xex99d2g023.jpg | GRAPHIC | 199627
28 | GRAPHIC | apre-20260812xex99d2g024.jpg | GRAPHIC | 101971
29 | GRAPHIC | apre-20260812xex99d2g025.jpg | GRAPHIC | 166224
30 | GRAPHIC | apre-20260812xex99d2g026.jpg | GRAPHIC | 141702
| Complete submission text file | 0001104659-26-094542.txt |  | 6045569

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
31 | EX-101.SCH | apre-20260812.xsd | EX-101.SCH | 3494
32 | EX-101.DEF | apre-20260812_def.xml | EX-101.DEF | 2844
33 | EX-101.LAB | apre-20260812_lab.xml | EX-101.LAB | 16593
34 | EX-101.PRE | apre-20260812_pre.xml | EX-101.PRE | 10903
44 | EXTRACTED XBRL INSTANCE DOCUMENT | apre-20260812x8k_htm.xml | XML | 4677

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 261265447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)